
Rescheduling Stalemate Leaves MSOs Facing a Billion Dollar Tax Reckoning
The Trump administration’s continued inaction on its promise to push ahead with the highly anticipated cannabis rescheduling project is now

The Trump administration’s continued inaction on its promise to push ahead with the highly anticipated cannabis rescheduling project is now

US cannabis rescheduling, much like President Donald Trump who is rightly credited for finally pushing it forward, has sucked all

It is now nearly two months since President Donald Trump surprised the global cannabis industry by signing an executive order to drag the highly-anticipated cannabis rescheduling

President Donald Trump’s executive order directing federal agencies to move cannabis from Schedule I to Schedule III of the Controlled

After two years of speculation, rumours, stock swings, broken promises, and political theatre, President Donald Trump officially signed an executive

Cannabis Rescheduling fervour has once again reached dramatic levels following media reports that President Donald Trump is considering pushing through

President Donald Trump has called on Senate Republicans to invoke the so-called ‘nuclear option’ to break the month-long government shutdown,

US Republicans have sharpened their sights on cannabis rescheduling, advancing legislation that would not only stop any hope of rescheduling

Cannabis stocks across North America have skyrocketed to their highest point so far this year, despite a lukewarm promise from

Terrance Cole, has been confirmed as the new permanent head of the Drug Enforcement Administration (DEA), and will now be responsible for the future of the landmark cannabis rescheduling project.

The US cannabis rescheduling project, which has been stuck in limbo since being ‘temporarily’ shelved six months ago, is now facing another existential threat from the government’s wide reaching budget.

The frozen US cannabis rescheduling process appears to be stuck in limbo for the foreseeable future, as the Drug Enforcement Administration’s (DEA’s) new management confirmed the process ‘remains pending’.

Cannabis rescheduling was thrown back into the spotlight last week as the new potential head of the Drug Enforcement Administration (DEA) said it would be a ‘priority’.

New court documents are said to provide new evidence of the US Drug Enforcement Administration’s bias against cannabis rescheduling, a process which it is overseeing.

This week has seen another frenetic torrent of executive orders issued by the newly inaugurated President Trump, causing chaos across almost all of America’s cornerstone institutions.

Two weeks after the shock suspension of proceedings in the landmark cannabis rescheduling process, it appears the US public believes it was the correct choice.

The US Drug Enforcement Administration (DEA) has formally requested that the Food and Drug Administration be ‘compelled’ by the court to give evidence at the upcoming cannabis rescheduling hearings.

As the DEA releases new details about the highly anticipated preliminary rescheduling hearing next week, efforts to remove the DEA